post-bg-494
calendary January 29, 2024

An inhalation device to facilitate smoking cessation is shown to be effective

Qnovia presented data from the first phase of studies of the effectiveness of the QN-01 device with the participation of volunteers.

Qnovia has submitted the study data to the US Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA).

A study involving 12 smoking volunteers assessed the delivery of nicotine at three different dosages using the QN-01 device. Participants took a short smoking break before taking the study. Using the QN-01 device was better at delivering nicotine into the bloodstream compared to existing nicotine replacement therapies.

According to Qnovia CEO Brian Quigley, quickly delivering a sufficient dose of nicotine can solve the problem of withdrawal symptoms when quitting smoking: “One of the reasons why quitting smoking is so difficult is the sharp jump in nicotine levels in the blood that cigarettes cause in a matter of seconds. The problem with existing nicotine replacement therapies is that they do not deliver nicotine at a high enough rate or concentration to effectively relieve withdrawal symptoms. Unfortunately, this leads to smoking relapse, and as a result there is a significant need for new methods of overcoming tobacco addiction.”

In addition, Quigley emphasized the safety of the QN-01. According to him, the formation of an aerosol in the device does not occur due to heating, due to which toxic substances are not released.

It is planned that in the US the nicotine replacement therapy device will be prescribed by a doctor. In terms of its mechanism of action, the device is breath activated by the user and delivers precise doses effectively via inhalation while addressing cue induced relapse behavior. The device tracks and displays real-time dosing to help patients successfully follow a 12-week step down regimen. All of this data is easily accessible on the device, smartphone or both.

According to Qnovia, smoking remains the leading preventable cause of death and disease in the world. Every year, smoking is a direct or indirect cause of death for eight million people worldwide. Every year in the US and UK, about 34 million smokers try to overcome their nicotine addiction.

References:
  1. https://pharmvestnik.ru/content/news/Qnovia-predstavila-dannye-issledovaniya-ustroistva-dlya-otkaza-ot-kureniya.html
  2. https://www.businesswire.com/news/home/20231129757219/en/Qnovia-Inc.-announces-positive-results-from-first-in-human-pharmacokinetic-and-safety-study-of-lead-asset-QN-01-a-prescription-inhaled-smoking-cessation-therapy
  3. https://www.qnovia.com/nrt/

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE